A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)
Clinical trial NCT03432364 · COMPLETED
Trial details
- NCT number
- NCT03432364
- Sponsor
- Sangamo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2022-11-17
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.